comprehensive -WSS

comprehensive

author：comprehensive 2025-09-29 01:35:14 - browse：362

Biogen announced a new round of cost cuts Tuesday, saying that it plans to save $700 million in operating costs and cut 1,000 jobs by 2025.

The company also released second quarter sales and earnings that handily topped the forecasts of Wall Street analysts. In early morning trading, Biogen shares rose more than 1%.

Biogen is attempting to recover from a series of corporate stumbles, the biggest of which involved the development and launch of the Alzheimer’s drug Aduhelm. The medicine was the first of a new class of disease-modifying Alzheimer’s drugs to be approved by the Food and Drug Administration. But doubts about the quality of the data behind the medicine meant that Medicare wouldn’t pay for it and doctors did not prescribe it. The resulting financial disaster cleaned out Biogen’s executive suite.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Amazon expands telehealth clinic nationwide

WSS

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

5 important ways Henrietta Lacks changed medical science

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Physician groups backed by private equity giant lobby on mergers

Mississippi candidates for statewide offices square off in party primaries

entertainment

comprehensive

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Novavax promises a turnaround & Lilly roils the obesity market

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What to expect as Trump is arraigned on his Jan 6. indictment

In age of alternative facts, a scholarly course on calling out crap

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

How one medical school became remarkably diverse

Physician groups backed by private equity giant lobby on mergers

focus

‘Oppenheimer’ and the risks of AI in health care

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Moderna hits safety problems in bold bid to reinvent medicine

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Wildfire pollution widens asthma inequities on Long Island

focus

hotspot

explore

entertainment